1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. MetAP

MetAP

Methionine Aminopeptidase

Methionine aminopeptidase (MetAP) is an enzyme that plays a crucial role in protein biosynthesis. MetAP is responsible for the removal of the N-terminal methionine residue from nascent polypeptide chains, which is essential for the proper folding, maturation and function of many proteins. MetAP1 and MetAP2 have different subcellular localizations and substrate specificities. MetAP1 is mainly involved in the processing of cytosolic proteins. MetAP2 is of particular interest in cancer research as it is involved in angiogenesis and has been targeted for anti-cancer drug development. Inhibition of MetAP2 can disrupt the growth and proliferation of cancer cells by interfering with the processing of certain proteins involved in angiogenesis[1][2].

MetAP Related Products (16):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-133016
    M8891
    Inhibitor 98.97%
    M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor with an IC50 of 54 nM and a Ki of 4.33 nM. M8891 does not inhibit MetAP-1 (IC50>10 µM). M8891 inhibits growth of primary endothelial cells as well as tumor cells and demonstrates antiangiogenic and antitumoral activity.
    M8891
  • HY-120868
    TP-004
    Inhibitor 98.89%
    TP-004 is a potent and reversible inhibitor of methionine aminopeptidase 2 (MetAP2), with an IC50 of 6 nM.
    TP-004
  • HY-128147
    MetAP-2-IN-6
    Inhibitor 99.55%
    MetAP-2-IN-6 is a MetAP2 inhibitor. MetAP-2-IN-6 can be used for research in conditions mediated by angiogenesis.
    MetAP-2-IN-6
  • HY-P4344
    Met-Gly-Pro-AMC
    Inhibitor 99.69%
    Met-Gly-Pro-AMC is a fluorescent peptide substrate of MetAP2.
    Met-Gly-Pro-AMC
  • HY-114196
    Aclimostat
    Inhibitor ≥98.0%
    Aclimostat (ZGN-1061) is a potent inhibitor of the MetAP2 enzyme and displays favorable efficacy and safety in preclinical studies. ZGN-1061 produced similar efficacy as beloranib for weight loss, improvements in metabolic parameters in a mouse model of obesity and insulin resistance, and concordant changes in gene transcription in HepG2 cells.
    Aclimostat
  • HY-168967
    BAY-277
    Inhibitor
    BAY-277 is a METAP2 degrader, with IC50 values of 5.8 nM and 5.9 nM for hMETAP2 and mMETAP2, respectively.
    BAY-277
  • HY-119062
    A-800141
    Inhibitor
    A-800141 is an orally active and selective MetAP2 inhibitor with an IC50 of 12 nM. A-800141 has weak inhibitory activity for MetAP1 (IC50 : 36 μM). GAPDH can be used as a biomarker to monitor the MetAP2 inhibition of A-800141. A-800141 has antiangiogenic and anticancer activity in a variety of xenograft tumor models.
    A-800141
  • HY-14811
    Beloranib
    Inhibitor
    Beloranib is a fumagillin-class methionine aminopetidase-2 (MetAP2) inhibitor. Beloranib decreases food intake, body weight, fat mass, and the size of adipocytes.
    Beloranib
  • HY-133016A
    (R)-M8891
    Inhibitor 98.67%
    (R)-M8891 (compound R-9) is a less active isomer of M8891. M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor.
    (R)-M8891
  • HY-109188
    Relzomostat
    Inhibitor
    Relzomostat is a methionine aminopeptidase 2 (MetAP2) inhibitor.Relzomostat may be useful for the research of obesity, type 2 diabetes, and other obesity-associated conditions.
    Relzomostat
  • HY-148442
    ecMetAP-IN-1
    Inhibitor
    ecMetAP-IN-1 (compound 17) is a potent ecMetAP inhibitor with an IC50 value of 2.086 µM.
    ecMetAP-IN-1
  • HY-13731
    PPI-2458
    Inhibitor 99.67%
    PPI-2458 is a potent, orally active, selective and irreversible inhibitor of methionine aminopeptidase-2 (MetAP-2). PPI-2458 can be used for arthritis and lymphoma research.
    PPI-2458
  • HY-146396
    Anticancer agent 51
    Inhibitor
    Anticancer agent 51 (compound 3d) is a potent anticancer agent with an Ki of 731.62 nM. Anticancer agent 51 shows anticancer activity. Anticancer agent 51 has the potential for the research of prostate cancer.
    Anticancer agent 51
  • HY-158006
    SDX-7539
    Inhibitor
    SDX-7539 is a selective inhibitor for Methionine aminopeptidase type 2 (MetAP2). SDX-7539 inhibits proliferarion of HUVECs with an IC50 of 120 μM. SDX-7539 exhibits antitumor activity in NSCLC xenograft athymic nude mice.
    SDX-7539
  • HY-126564
    Ebelactone A
    Inhibitor
    Ebelactone A is a mycolic acid β-lactone, which exhibits inhibitory activity for esterase, lipase, fMet aminopeptidase (fMet AP) and PNBase, with IC50s of 56, 3, 8 and 7.5 μM, respectively. Ebelactone A inhibits cutinase, exhibits plants protective potency against Erysiphe graminis.
    Ebelactone A
  • HY-14811A
    Beloranib hemioxalate
    Inhibitor
    Beloranib (ZGN-440; ZGN-433) hemioxalate is a fumagillin-class methionine aminopetidase-2 (MetAP2) inhibitor. Beloranib hemioxalate decreases food intake, body weight, fat mass, and the size of adipocytes. Beloranib hemioxalate plays an important role in anti-obesity activity or obesity research.
    Beloranib hemioxalate